Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 705 of 1,261
  1. US 9278124

    Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods

    HALOZYME, INC. · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  2. US 9278110

    Anti-regurgitation and/or anti-gastrooesophageal reflux composition, preparation and uses

    UNITED PHARMACEUTICALS · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  3. US 9278113

    Titanium dioxide nanotubes for production and delivery of nitric oxide and methods for production thereof

    The Board of Regents of the University of Texas System · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  4. US 9278112

    Citrate containing beverage

    The Regents of the University of California · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  5. US 9278089

    Method of treating HCV infection with a small molecule CHK2 inhibitor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  6. US 9278090

    Methods of preventing the development of mucositis and related disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  7. US 9278068

    Vesicle compositions

    The Board of Regents of the University of Texas System · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  8. US 9278088

    Methods for identifying analgesic agents

    Xenon Pharmaceuticals Inc. · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  9. US 9277799

    Henna applicator device and a method of operating the same

    UNITED ARAB EMIRATES UNIVERSITY · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  10. US 9278066

    Topical pharmaceutical foam composition

    Precision Dermatology, Inc. · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  11. US 9278987

    Functionally-modified oligonucleotides and subunits thereof

    Sarepta Therapeutics, Inc. · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  12. US 9278116

    Compositions and methods for treatment of pain

    Princeton Biotechnology Corporation · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  13. US 9278091

    Compounds for the treatment of Clostridium difficile associated disease

    SUMMIT THERAPEUTICS PLC · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  14. US 9277748

    Agonist/antagonist compositions and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  15. US 9278901

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  16. US 9278938

    Production method of imidazole derivatives

    Takeda Pharmaceutical Company Limited · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  17. EP 2988750

    VERWENDUNG VON LANDIOLOLHYDROCHLORID BEI DER LANGZEITBEHANDLUNG VON TACHYARRHYTHMIEN

    AOP ORPHAN PHARMACEUTICALS AG [AT] · Granted Mar 2, 2016 · Expires Feb 26, 2036

    granted
  18. US 9271949

    Compositions comprising acidic extracts of mastic gum

    REGENERA PHARMA LTD. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  19. US 9274109

    Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same

    Aeon Medix Inc. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  20. US 9273277

    Compositions comprising nanostructures for cell, tissue and artificial organ growth, and methods for making and using same

    The Regents of the University of California · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  21. US 9273143

    Methods and compositions comprising a combination of an anti-ErbB3 antibody and an anti-EGFR antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  22. US 9273047

    Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  23. US 9273008

    Dual-acting imidazole antihypertensive agents

    Theravance Biopharma R&D IP, LLC · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  24. US 9272990

    Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis

    AMIRA PHARMACEUTICALS, INC. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.